Aprea Therapeutics, Inc. APRE

Set alert

Price alert · APRE

All alert types
0.49 USD +0.01 +1.32%

At close · Nov 2

0.48 -0.01 -1.28%

After hours · Nov 2, 4:00 PM ET

Bid
0.48 × 2
Ask
0.50 × 2
0.488 Day range 0.5199
0.41 52-week range 1.49
YTD
-42.44%
1 year
-64.93%
Open
0.50
Prev close
0.4846
Mkt cap
6.18M
Vol
88.99K
Avg vol
310.11K
EPS
-0.96
P/E
0.00
Div yield
0.00%
More statistics
Low
0.488
High
0.5199
Forward P/E
-3.08
Beta
1.74
Short ratio
0.55
Inst. own
43.85%
Dividend
0.00
Ex-div date
Earnings
Aug 12, 2024
50-d avg
3.48
200-d avg
4.17
1y target
15.67

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for APRE has not been loaded yet. Try again in a moment.

Revenue & Expenses

Other Income → Expenses: $1.36MExpenses → Gross Loss: $7.86MExpenses → Selling, General & Admin: $6.46MExpenses → Research & Development: $9.36MOther Operating Income → Expenses: $9.36MNet Loss → Expenses: $12.96MRevenue → Cost of Revenue: $1.50MOther Income$1.36MOther Operating Income$9.36MNet Loss$12.96MCost of Revenue$9.36MExpenses$23.68MGross Loss$7.86MSelling, General & Admin$6.46MResearch & Development$9.36MRevenue$1.50M

Latest period ending Dec 31, 2025 · select a line to chart its full history

APRE annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
285.76K1.50M583.23K00
285.76K1.50M583.23K00
-13.23M-14.32M-15.47M-113.39M-37.45M
-12.60M-12.96M-14.29M-112.66M-37.13M
-1.93-2.35-3.95-67.99-34.88
APRE annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
14.64M22.89M21.65M28.79M53.08M
15.93M23.98M22.65M30.16M56.82M
3.49M4.67M5.70M4.51M7.32M
12.44M19.31M16.95M25.64M49.51M
APRE annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-12.89M-13.56M-12.18M-25.01M-37.69M
4.64M14.82M5.14M682.97K1.75M
-8.25M1.25M-7.13M-24.33M-35.94M